(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OLVOXA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

OLVOXA

ST13

US500000079273193

Class

9, 10, 44

Filing

79273193

Registration

6166336

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

39

Latest update

10/07/2025

Classification

Registered

Trademark type

Word

Nice classes

9, 10, 44

Filing date

09/16/2019

Registration date

10/06/2020

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/06/2020

Last transaction

10/07/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

34

Owner location

FR

Examiner

CARR,PATRICK C

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BIOFARMA

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 9Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipmentfor receivingprocessingtransmitting and displaying data; downloadable computer software for controlling and managing patient medical information; downloadable computer programs for providing information on health and well-being; downloadable computer software enabling users to keep track of their symptomsphysical activity and vital signs and to record and share information with healthcare professionals; downloadable mobile application software for healthcare professionals and patients containing health information and diagnostic data relating theretofor use by healthcare professionals for monitoring and diagnosing medical conditions and the treatment thereof

Class 10

Medical devices for monitoring vital signsblood properties and respiratory events for medical use; diagnostic devices for medical usemedical diagnostic instruments for the analysis of bodily fluids and medical diagnostic apparatus for testing DNA and RNA samples; physiological measuring and monitoring apparatus for medical use in the nature of medical apparatus for monitoring blood oxygen saturationblood gas concentrationsblood properties and respiratory events; automatic analyzers for medical useskin moisture analyzers for medical purposesanalyzers for bacterial identification for medical purposesMedical devices for monitoring blood oxygen saturationblood gas concentrationsvital signsblood properties and respiratory events; health monitoring and surveillance devices consisting of blood pressure monitorsthermometerspedometers; electrical or electronic sensors for medical use to be worn by a human to gather human biometric dataspecifically to detectmeasureprocesscollectrecord and transmit health-related variables used to measure biometric data for medical use

Class 44

Medical services; provision of medical testing services for diagnosis or treatment and of information in the field of personalized medical care; consultancy services relating to health; pharmaceutical consultancy; telemedicine services; medical diagnosticmonitoring and reporting services; advisory services relating to health; health screening services in the fields of human physiologyactivitysleepsleep apneacardiovascular healthdermatologyhearingneurologycancerendocrinologyhormones and metabolic health

Publications

History of USPTO decisions and trademark events.

39 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/06/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/14/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/25/2021

FIMP

FINAL DISPOSITION PROCESSED

01/25/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/06/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

10/06/2020

GPNX

NOTIFICATION PROCESSED BY IB

07/31/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/21/2020

PUBO

PUBLISHED FOR OPPOSITION

07/21/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/15/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/15/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/01/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/15/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

06/11/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/11/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

06/11/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/11/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

06/10/2020

GNFR

FINAL REFUSAL E-MAILED

06/10/2020

CNFR

FINAL REFUSAL WRITTEN

06/10/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/18/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/18/2020

ALIE

ASSIGNED TO LIE

05/18/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/12/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/21/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/21/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/21/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/21/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/21/2020

RFNT

REFUSAL PROCESSED BY IB

02/01/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/11/2020

RFRR

REFUSAL PROCESSED BY MPU

01/11/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/18/2019

CNRT

NON-FINAL ACTION WRITTEN

12/17/2019

MAFR

APPLICATION FILING RECEIPT MAILED

12/17/2019

DOCK

ASSIGNED TO EXAMINER

12/16/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/13/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

12/12/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/05/2019

Continuous trademark protection

Get notified about every new filing that threatens OLVOXA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.